Abstracts: oral presentations.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 450, doi. 10.1177/0961203308090216
- Publication type:
- Article
Works matching IS 09612033 AND DT 2008 AND VI 17 AND IP 5
Results: 23
1
2
AUTHORS INDEX.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 512, doi. 10.1177/0961203308090218
- Publication type:
- Article
3
Poster Presentations.
- Published in:
- 2008
- Publication type:
- Abstract
4
Oral Presentations.
- Published in:
- 2008
- Publication type:
- Abstract
5
Lupus and pregnancy: ten questions and some answers.
- Published in:
- 2008
- By:
- Publication type:
- Question & Answer
6
Sex hormones and systemic lupus erythematosus.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 412, doi. 10.1177/0961203308090026
- By:
- Publication type:
- Article
7
The Janus of lupus - benefits and risks with B-cell therapy.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 447, doi. 10.1177/0961203308090033
- By:
- Publication type:
- Article
8
Pathogenic anti-nucleosome antibodies.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 431, doi. 10.1177/0961203308090030
- By:
- Publication type:
- Article
9
Current treatment of lupus nephritis.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 426, doi. 10.1177/0961203308090029
- By:
- Publication type:
- Article
10
T-regulatory cells in systemic lupus erythematosus.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 421, doi. 10.1177/0961203308090028
- By:
- Publication type:
- Article
11
New developments in lupus-associated antiphospholipid syndrome.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 443, doi. 10.1177/0961203308090032
- By:
- Publication type:
- Article
12
Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future - the EULAR recommendations for the management of SLE and the use of end-points in clinical trials.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 437, doi. 10.1177/0961203308090031
- By:
- Publication type:
- Article
13
Pathogenic role of antiphospholipid antibodies.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 405, doi. 10.1177/0961203308090025
- By:
- Publication type:
- Article
14
Treating patients with lupus with B-cell depletion.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 400, doi. 10.1177/0961203308090024
- By:
- Publication type:
- Article
15
The innate immune system in SLE: type I interferons and dendritic cells.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 394
- By:
- Publication type:
- Article
16
Pathogenesis of cutaneous lupus erythematosus.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 389, doi. 10.1177/0961203308090019
- By:
- Publication type:
- Article
17
Pathogenic role of auto-antibodies against complement components in systemic lupus erythematosus.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 385, doi. 10.1177/0961203308090018
- By:
- Publication type:
- Article
18
Neuropsychiatric lupus and infectious triggers.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 380, doi. 10.1177/0961203308090017
- By:
- Publication type:
- Article
19
Lupus and the central nervous system.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 376, doi. 10.1177/0961203308090112
- By:
- Publication type:
- Article
20
Apoptosis in the pathogenesis of systemic lupus erythematosus.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 371, doi. 10.1177/0961203308089990
- By:
- Publication type:
- Article
21
Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 368, doi. 10.1177/0961203308089989
- By:
- Publication type:
- Article
22
Systemic lupus erythematosus and cardiovascular disease.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 364
- By:
- Publication type:
- Article
23
Preface.
- Published in:
- Lupus, 2008, v. 17, n. 5, p. 363, doi. 10.1177/0961203308089987
- By:
- Publication type:
- Article